x

Search for a clinical trial

* (*) mandatory field

185 Result(s)

Sort by

Recruiting trial = Recruiting trial
; Ongoing trial = Ongoing trial
; Funded by an IRDiRC member =

National clinical trial(s)

AUSTRIA

OBERÖSTERREICH
LINZ

AUSTRIA

TIROL
INNSBRUCK

AUSTRIA

WIEN
WIEN

Ongoing trial
An Open-label, Phase 1b/2 Study of ACP-196 in Subjects with Waldenström Macroglobulinemia - AT
Allgemeines Krankenhaus der Stadt Wien
Klinische Abteilung für Hämatologie und Hämostaseologie

FRANCE

BRETAGNE
RENNES

FRANCE

ILE-DE-FRANCE
PARIS

FRANCE

ILE-DE-FRANCE
PARIS

A phase IIa trial testing the efficacy of Bortezomib (Velcade) in patients with advanced Waldenström macroglobulinemia (WM2)
CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
Service d'Hématologie clinique

GERMANY

Baden-Württemberg
HEIDELBERG

GERMANY

Bayern
MÜNCHEN

SPAIN

Castilla - León
SALAMANCA

SPAIN

Castilla - León
SALAMANCA

An Open-label, Phase 1b/2 Study of ACP-196 in Subjects with Waldenström Macroglobulinemia - ES (terminated)
Hospital Clínico Universitario de Salamanca
Servicio de Hematología

SPAIN

Cataluña
BARCELONA

SPAIN

Madrid
MAJADAHONDA

Recruiting trial
Ongoing trial
Extended Treatment Protocol for Subjects Continuing to Benefit From Ibrutinib After Completion of Ibrutinib Clinical Trials (Phase IV) - ES
Hospital Universitario Puerta de Hierro - Majadahonda
Servicio de Hematología y Hemoterapia

ITALY

LOMBARDIA
ROZZANO

Ofatumumab-Bendamustine For Relapsed-Refractory Indolent Lymphoma: A Multicenter Phase 2 Trial
IRCCS Istituto Clinico Humanitas
U.O. Oncologia Medica ed Ematologia

SPAIN

Comunidad Valenciana
VALENCIA

DYNAMO: A Phase 2 Study of IPI-145 in Subjects with Refractory Indolent Non-Hodgkin Lymphoma - ES (Completed)
Hospital Universitario y Politécnico La Fe
Servicio de Oncología Médica

UNITED KINGDOM

South Glamorgan
CARDIFF

FRANCE

AUVERGNE-RHONE-ALPES
PIERRE-BENITE

GERMANY

Nordrhein-Westfalen
KÖLN

GERMANY

Nordrhein-Westfalen
MÜNSTER

Recruiting trial
Ongoing trial
A Phase I/II Safety, Dose Finding and Feasibility Trial of MB-CART19.1 in Patients With Relapsed or Refractory CD19 Positive B Cell Malignancies
Universitätsklinikum Münster
Klinik für Kinder- und Jugendmedizin - Pädiatrische Hämatologie und Onkologie

SPAIN

Madrid
MADRID

Recruiting trial
Ongoing trial
A phase I/II, multicenter, open-label study of MAK683 in adult patients with advanced malignancies - ES
Hospital Universitario 12 de Octubre
Unidad de Ensayos Clínicos de Fase Temprana en Hematología

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
ADDRESS: NOT PROVIDED - BE

FRANCE

BOURGOGNE-FRANCHE-COMTE
BESANÇON

FRANCE

ILE-DE-FRANCE
PARIS

Treatment of aggressive lymphoma in adults: NHL 98
CHU Paris-GH St-Louis Lariboisière F.Widal - Hôpital Saint-Louis
Institut Universitaire d'Hématologie

FRANCE

PAYS DE LA LOIRE
NANTES

FRANCE

PROVENCE-ALPES-COTE D'AZUR
MARSEILLE

Intensive sequential chemotheray in non hodgkin lymphoma (NLH) of patients suffering from HIV- CIS VIH 02 (Phase IV) - trial stopped -
CLCC Institut Paoli Calmettes
Unité d'Evaluation Thérapeutique en Onco-Hématologie (ETHO)

GERMANY

Baden-Württemberg
TÜBINGEN

Pegfilgrastim vs. filgrastim - comparison of mobilized blood stem cells in patients with Non-Hodgkin lymphoma (Phase II) - DE
Department für Innere Medizin - Medizinische Universitätsklinik Tübingen
Innere Medizin II - Onkologie, Hämatologie, Klinische Immunologie, Rheumatologie und Pulmologie

ITALY

EMILIA ROMAGNA
BOLOGNA

Recruiting trial
Ongoing trial
Study of Lenalidomide(Revlimid) Plus Rituximab (Revlirit Regimen) in Elderly Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
Policlinico S. Orsola-Malpighi - Area S. Orsola
Dipartimento di Ematologia e Scienze Oncologiche

NETHERLANDS

Gelderland
NIJMEGEN

NETHERLANDS

Noord-Holland
AMSTERDAM

Low dose radiotherapy (2x 2 Gy) in low grade Non-Hodgkin lymphomas (Completed)
Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
Afdeling Radiotherapie

NETHERLANDS

Zuid-Holland
ROTTERDAM

Combination Chemotherapy Plus Filgrastim With or Without Rituximab in Treating Older Patients With Non-Hodgkin's Lymphoma
Erasmus MC, Locatie Daniel den Hoed
Erasmus MC Kanker Instituut Daniel den Hoed

SPAIN

Cataluña
ESPLUGUES DE LLOBREGAT

SPAIN

Comunidad Valenciana
VALENCIA

UNITED KINGDOM

Greater Manchester
ADDRESS: NOT PROVIDED - UK

BELGIUM

ARRONDISSEMENT BRUSSELS-CAPITAL
BRUSSELS

Ongoing trial
STEP: Sorafenib Long Term Extension Program - BE
Cliniques Universitaires UCL Saint-Luc
Pneumologie_Oncologie thoracique

Multinational clinical trial(s)

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US

UNITED STATES

Washington
ADDRESS: NOT PROVIDED - US